LTA4 Hydrolase

February 19, 2023

Currently, a couple of two key methods to disease-modifying therapy in ATTR: stabilizing the TTR tetramer hence reducing its amyloidogenicity and/or suppression of TTR production with gene silencing therapies

Currently, a couple of two key methods to disease-modifying therapy in ATTR: stabilizing the TTR tetramer...

However, it did not confer responsiveness to PlxnA2 (Fig 7DC7H). Open in a separate window Fig...

Sequence-reads were in turn trimmed according to BWAs C q algorithm [55] and the sequence reads...